Augmented immunogenicity of tumor cell homogenates produced by infection with influenza virus.
D000818:Animals; D000951:Antigens, Neoplasm; D002286:Carcinoma, Ehrlich Tumor / Q000276:immunology; D002462:Cell Membrane / Q000276:immunology; D003016:Clostridium perfringens / Q000201:enzymology; D005354:Fibrosarcoma / Q000276:immunology; D006084:Graft Rejection; D006649:Histocompatibility Antigens; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007167:Immunotherapy; D007456:Iodine Isotopes; D051379:Mice; D009368:Neoplasm Transplantation; D009439:Neuraminidase / Q000378:metabolism; D009522:Newcastle disease virus / Q000201:enzymology; D009975:Orthomyxoviridae / Q000201:enzymology / Q000276:immunology*
D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens; D007456:Iodine Isotopes; D009439:Neuraminidase